Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Mass Balance Study of [14C]ABSK011 in Healthy Adult Male Chinese Participants

NCT06896760 is registered in ClinicalTrials.gov with Abbisko Therapeutics Co, Ltd as lead sponsor.

NCT NCT06896760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06896760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Mass Balance Study of [14C]ABSK011 in Healthy Adult Male Chinese Participants
Lead sponsor
Abbisko Therapeutics Co, Ltd
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 7, 2025
Completion date
April 7, 2026
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects